These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18719053)

  • 1. Elevated free IGF2 levels in localized, early-stage breast cancer in women.
    Espelund U; Cold S; Frystyk J; Ørskov H; Flyvbjerg A
    Eur J Endocrinol; 2008 Nov; 159(5):595-601. PubMed ID: 18719053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating IGF system and treatment outcome in epithelial ovarian cancer.
    Huang YF; Cheng WF; Wu YP; Cheng YM; Hsu KF; Chou CY
    Endocr Relat Cancer; 2014 Apr; 21(2):217-29. PubMed ID: 24273235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin administration is associated with dose-related changes in IGF bioavailability.
    Narayanan RP; Gittins M; Siddals KW; Oliver RL; Hudson JE; White A; Durrington P; Davies RR; Rutter MK; Gibson JM
    Eur J Endocrinol; 2013 Apr; 168(4):543-8. PubMed ID: 23333902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of adiponectin multimers and the IGF axis in humans with a heterozygote mutation in the tyrosine kinase domain of the insulin receptor gene.
    Højlund K; Beck-Nielsen H; Flyvbjerg A; Frystyk J
    Eur J Endocrinol; 2012 Mar; 166(3):511-9. PubMed ID: 22189999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
    Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
    Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of ghrelin and the GH/IGF axis to high altitude.
    Riedl S; Kluge M; Schweitzer K; Waldhör T; Frisch H
    Eur J Endocrinol; 2012 Jun; 166(6):969-76. PubMed ID: 22416077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.
    Frystyk J; Schou AJ; Heuck C; Vorum H; Lyngholm M; Flyvbjerg A; Wolthers OD
    Eur J Endocrinol; 2013 Jan; 168(1):1-8. PubMed ID: 23038624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men.
    Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L
    Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
    Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
    Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study.
    Argüelles B; Barrios V; Pozo J; Muñoz MT; Argente J
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4087-92. PubMed ID: 11095437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study.
    Yeap BB; Chubb SA; McCaul KA; Ho KK; Hankey GJ; Norman PE; Flicker L
    Eur J Endocrinol; 2011 May; 164(5):715-23. PubMed ID: 21378090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
    Krassas GE; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen JW; Flyvbjerg A
    J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.